Skip to main content
Shivalik Rasayan Ltd. logo

Shivalik Rasayan Ltd. — Investor Relations & Filings

Ticker · SHIVALIK ISIN · INE788J01021 LEI · 335800FEB4CFANKSV783 BSE.NS Manufacturing
Open in API
Filings indexed 220 across all filing types
Latest filing 2025-02-11 Regulatory Filings
Country IN India
Listing BSE.NS SHIVALIK

About Shivalik Rasayan Ltd.

https://shivalikrasayan.com/

Shivalik Rasayan Ltd. is a diversified chemical and pharmaceutical manufacturer specializing in the production of organophosphorus-based agrochemicals and high-potency active pharmaceutical ingredients (APIs). The company operates through two primary business segments: Agrochemicals and Pharmaceuticals. In the agrochemical sector, it is a leading producer of technical-grade insecticides, including Dimethoate and Malathion. Its pharmaceutical division focuses on the development and manufacture of oncology APIs and finished dosage forms, utilizing advanced research and development capabilities to serve global markets. Shivalik Rasayan maintains state-of-the-art manufacturing facilities designed to meet international regulatory standards, positioning itself as a key supplier of specialized chemical intermediates and complex therapeutic solutions for the healthcare and agricultural industries.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Regulatory Filings
2025-02-11 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a formal communication from Shivalik Rasayan Limited to stock exchanges (BSE and NSE) dated February 11, 2025. It announces the outcome of a Board Meeting where the Board approved the Un-Audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2024. The document references Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to quarterly financial results disclosures. It includes mention of annexures containing the financial results and a limited review report by auditors. The document is an announcement of the financial results and the board meeting outcome, not the full financial report itself. The length is 2724 characters, which is relatively short and consistent with an announcement rather than a full interim report. Therefore, this document fits best under the category of Interim / Quarterly Report (IR) because it contains substantive financial data for a period shorter than a full fiscal year (quarter and nine months), and it is not merely a notice or certification. The presence of unaudited financial results and segment-wise data confirms it is a financial report rather than just an announcement or certification.
2025-02-11 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-02-04 English
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is an intimation letter from Shivalik Rasayan Limited to stock exchanges about an upcoming Board Meeting scheduled for February 11, 2025. The purpose of the meeting includes considering and approving un-audited financial results for the quarter and nine months ended December 31, 2024. The document references regulatory compliance under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and insider trading regulations. The document is a notification of a board meeting and the agenda, not the financial results report itself. It is short (2405 characters) and serves as an announcement rather than containing financial data or detailed report content. Therefore, it fits best under Board/Management Information (MANG) as it relates to board meeting intimation and management disclosures.
2025-02-04 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming details about securities dematerialized/rematerialized during the quarter ended December 31, 2024. It is a compliance certificate issued by the company and its registrar and share transfer agent. The document does not contain financial statements or detailed financial data, nor is it a report like an annual or quarterly report. It is primarily a regulatory compliance certificate related to securities and shareholding records. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and certification documents that do not fit other specific categories.
2025-01-10 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter from Shivalik Rasayan Limited addressed to stock exchanges (BSE and NSE) informing about the closure of the trading window for insiders due to upcoming financial results announcement. It references the SEBI regulations on insider trading and mentions the trading window closure period from January 1, 2025, until after the declaration of the unaudited financial results for the quarter ending December 31, 2024. The document does not contain any financial data or results itself, nor does it include a report or presentation. It is an announcement related to trading restrictions ahead of financial results disclosure. The document length is short (2068 characters), and it is clearly an announcement rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2024-12-28 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.